Scinai Immunotherapeutics Ltd. - ADSs (BVXV)

Historical Holders from Q2 2015 to Q4 2022

Symbol
BVXV
Type / Class
Equity / ADSs
Shares outstanding
592,878
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 4.9% $26,727 29,051 SABBY MANAGEMENT, LLC 31 Dec 2024

Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2022 Q4 0 $0 -$153,000 0
2022 Q3 209,677 $153,000 -$107,274 $0.7292 10
2022 Q2 333,825 $389,000 -$12,455 $1.17 13
2022 Q1 328,283 $541,300 -$97,445 $1.66 15
2021 Q4 335,947 $789,000 +$204,452 $2.35 13
2021 Q3 253,999 $558,000 -$196,362 $2.20 13
2021 Q2 311,298 $891,000 -$9,852 $2.86 15
2021 Q1 283,618 $1,077,000 +$263,027 $3.79 17
2020 Q4 221,471 $622,000 -$16,795,397 $2.81 10
2020 Q3 539,410 $21,088,000 +$2,404,448 $39.10 18
2020 Q2 506,304 $11,519,000 +$2,223,472 $22.75 14
2020 Q1 404,424 $3,114,000 -$681,032 $7.70 7
2019 Q4 476,956 $4,430,000 +$658,000 $9.20 11
2019 Q3 405,665 $2,410,000 $5.72 7
2019 Q2 405,665 $2,337,000 -$63,080 $5.76 7
2019 Q1 417,334 $2,266,000 -$139,526 $5.43 9
2018 Q4 446,374 $2,129,000 +$105,507 $4.77 10
2018 Q3 448,784 $2,513,000 +$7,535 $5.60 11
2018 Q2 447,247 $2,981,000 -$159,059 $6.67 11
2018 Q1 475,746 $2,582,000 -$55,242 $5.42 14
2017 Q4 496,218 $2,606,000 +$130,259 $5.33 11
2017 Q3 106,181 $689,000 +$555,135 $7.14 8
2017 Q2 28,497 $164,000 -$254,500 $8.57 5
2017 Q1 72,719 $366,000 +$221,000 $5.79 5
2016 Q4 39,000 $102,000 -$12,000 $3.35 3
2016 Q3 32,486 $119,000 -$3,000 $3.67 3
2016 Q2 33,393 $118,000 +$2,000 $3.53 3
2016 Q1 32,793 $122,000 +$3,000 $3.73 3
2015 Q4 32,000 $126,000 -$60,000 $3.94 2
2015 Q3 48,159 $177,000 -$216,090 $3.71 5
2015 Q2 100,047 $495,000 +$495,000 $4.95 5